← FDA DRUG APPROVALS

FDA ANDA · ANDA215969

ATROPINE SULFATE

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA215969
TYPE
ANDA
ORIGINAL APPROVAL
2024-07-03
LATEST ACTION
2024-07-03
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ATROPINE SULFATEPrescription
ATROPINE SULFATE 1MG/ML (1MG/ML) · SOLUTION · INTRAVENOUS
ATROPINE SULFATEPrescription
ATROPINE SULFATE 0.4MG/ML (0.4MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2024-07-03UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →